However, differentiation of embryonic stem cells (ESCs) or induced pluripotent stem cells (IPSCs) to insulin-secreting cells by mimicking the intercellular signaling during the β cells development, is an ambitious hope for cell therapy in diabetes. The gene discussed is INS; the disease is diabetes mellitus.